SkylineDX Overview

  • Year Founded
  • 2005

Year Founded

  • Status
  • Private

  • Employees
  • 75

Employees

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 6

SkylineDX General Information

Description

Developer of diagnosis technology designed to offer gene signature-based diagnostic test services. The company's technology determines the type or status of the disease and predicts a patient's response to a specific treatment for individualized medical care, based on the genomic profile of the disease, enabling care providers and patients to get help in decision-making on whether a therapy will work or surgery is necessary.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Lichtenauerlaan 40
  • Brainpark II - Building XI
  • 3062 ME Rotterdam
  • Netherlands
+31 010
Primary Industry
Diagnostic Equipment
Corporate Office
  • Lichtenauerlaan 40
  • Brainpark II - Building XI
  • 3062 ME Rotterdam
  • Netherlands
+31 010

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

SkylineDX Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Later Stage VC 01-Jan-2024 Completed Generating Revenue
6. Later Stage VC 21-Dec-2021 Completed Generating Revenue
5. Later Stage VC 02-Sep-2019 Completed Generating Revenue
4. Later Stage VC 26-Jul-2018 Completed Generating Revenue
3. Early Stage VC (Series B) 05-Jan-2009 Completed Generating Revenue
2. Early Stage VC (Series A) 05-Oct-2007 Completed Generating Revenue
1. University Spin-Out 01-Jan-2005 Completed Startup
To view SkylineDX’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

SkylineDX Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of diagnosis technology designed to offer gene signature-based diagnostic test services. The company's technol
Diagnostic Equipment
Rotterdam, Netherlands
75 As of 2025

Eysins, Switzerland
 

Boston, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

SkylineDX Competitors (26)

One of SkylineDX’s 26 competitors is AliveDx, a Formerly VC-backed company based in Eysins, Switzerland.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
AliveDx Formerly VC-backed Eysins, Switzerland
Foundation Medicine Formerly VC-backed Boston, MA
Decipher Urologic Cancers Formerly VC-backed San Diego, CA
Myriad Genetics Corporation Salt Lake City, UT
Agendia Venture Capital-Backed Irvine, CA
You’re viewing 5 of 26 competitors. Get the full list »

SkylineDX Patents

SkylineDX Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4133490-A1 Method for identifying signatures for predicting treatment response Inactive 06-Apr-2020
US-20230223107-A1 Method for identifying signatures for predicting treatment response Pending 06-Apr-2020
WO-2021206544-A1 Method for identifying signatures for predicting treatment response Inactive 06-Apr-2020
AU-2019310636-A1 Gene signatures for predicting metastasis of melanoma and patient prognosis Active 25-Jul-2018
AU-2019310636-B2 Gene signatures for predicting metastasis of melanoma and patient prognosis Active 25-Jul-2018 C12Q1/6886
To view SkylineDX’s complete patent history, request access »

SkylineDX Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

SkylineDX Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
Amsterdam UMC Ventures Holding Venture Capital Minority
Novalis LifeSciences Venture Capital Minority
Utrecht Holdings Not-For-Profit Venture Capital Minority
Van Herk Groep Real Estate Minority
Erasmus MC Biomedical Fund Venture Capital Minority
You’re viewing 5 of 6 investors. Get the full list »

SkylineDX Investments (1)

SkylineDX’s most recent deal was a Later Stage VC with DCPrime. The deal was made on 28-Oct-2014.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
DCPrime 28-Oct-2014 Later Stage VC Drug Discovery
To view SkylineDX’s complete investments history, request access »

SkylineDX FAQs

  • When was SkylineDX founded?

    SkylineDX was founded in 2005.

  • Where is SkylineDX headquartered?

    SkylineDX is headquartered in Rotterdam, Netherlands.

  • What is the size of SkylineDX?

    SkylineDX has 75 total employees.

  • What industry is SkylineDX in?

    SkylineDX’s primary industry is Diagnostic Equipment.

  • Is SkylineDX a private or public company?

    SkylineDX is a Private company.

  • What is SkylineDX’s current revenue?

    The current revenue for SkylineDX is .

  • How much funding has SkylineDX raised over time?

    SkylineDX has raised $29.1M.

  • Who are SkylineDX’s investors?

    Amsterdam UMC Ventures Holding, Novalis LifeSciences, Utrecht Holdings, Van Herk Groep, and Erasmus MC Biomedical Fund are 5 of 6 investors who have invested in SkylineDX.

  • Who are SkylineDX’s competitors?

    AliveDx, Foundation Medicine, Decipher Urologic Cancers, Myriad Genetics, and Agendia are some of the 26 competitors of SkylineDX.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process